Quantcast

Latest MDV3100 Stories

2010-04-14 17:31:00

SAN FRANCISCO and TOKYO, April 14 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) and Astellas Pharma Inc.

2009-10-23 07:00:00

SAN FRANCISCO, Oct. 23 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced the appointment of Hank Mansbach, M.D., as vice president of medical affairs. Dr.

2009-09-23 07:00:00

SAN FRANCISCO, Sept. 23 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced treatment of the first patient in a Phase 3 clinical trial of the investigational drug MDV3100 in advanced prostate cancer.

2009-06-02 08:23:00

-- Findings Presented at American Society of Clinical Oncology 2009 Annual Meeting and Included in Best of ASCO(R) Educational Program -- SAN FRANCISCO, June 2 /PRNewswire-FirstCall/ -- Medivation, Inc.

2009-05-11 15:01:00

- Conference Call Today at 4:30 p.m. Eastern Time - SAN FRANCISCO, May 11 /PRNewswire-FirstCall/ -- Medivation, Inc.

2009-04-23 07:00:00

SAN FRANCISCO, April 23 /PRNewswire-FirstCall/ -- Medivation, Inc.

2009-04-10 15:36:38

A new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs.

2009-04-09 07:39:41

A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels – a marker for tumor growth – in men with advanced prostate cancer for whom traditional treatment options have failed.

2009-04-09 00:36:02

An experimental drug lowers prostate specific antigen levels -- a marker for tumor growth -- in men with advanced prostate cancer, U.S. researchers say.


Word of the Day
plim
  • To swell, as grain or wood with water.
The word 'plim' is probably a variant of the word 'plum'.
Related